A single lot of apixaban 5-mg tablets is being recalled nationwide following a customer complaint about the wrong dosage, the manufacturer has announced. The US Food and Drug Administration (FDA) ...

Eliquis is prescribed to treat or prevent blood clots and to reduce the risk of stroke in certain adults. Its dosage varies based on the condition being treated and other factors. The standard Eliquis ...

The cost of Eliquis can vary based on your insurance coverage, the pharmacy you use, and whether you’re eligible for cost assistance. The price of 2.5-mg and 5-mg Eliquis tablets is likely the same, ...

The company is voluntarily recalling one lot of Eliquis after a patient discovered that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets. Bristol-Myers Squibb (BMS) is ...

PRINCETON, NJ — One lot of apixaban (Eliquis, Bristol-Myers Squibb) 5-mg tablets is being voluntarily recalled after a consumer complained that a bottle labeled as Eliquis 5 mg actually contained ...

Bristol-Myers Squibb Company has announced that the company is voluntarily recalling one lot of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the US to wholesalers ...

Eliquis (apixaban) is a prescription drug used to help prevent and treat certain kinds of blood clots. This article gives details on Eliquis and cost, prices with and without Medicare, and resources ...

Credit: Getty Images. The recall is specific to Eliquis 5mg Tablets (60-count bottle) Lot# HN0063 with expiration date of September 2019. Bristol-Myers Squibb is recalling one lot of Eliquis (apixaban ...

Eliquis (apixaban) is a prescription oral tablet used to reduce the risk of stroke in certain adults and to treat or prevent blood clots in certain adults and children. The Eliquis dosage you’re ...

The Food and Drug Administration (FDA) has approved the first generics of Eliquis (apixaban; Bristol-Myers Squibb and Pfizer) tablets. The generic version will be dispensed with a Medication Guide to ...

Drug firm Lupin said it has received a tentative nod from the US health regulator to market its generic Apixaban tablets. The company has received the tentative approval from the United States Food ...